Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : GlaxoSmithKline Research & Development Ltd
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
A multicentre, randomised, double-blind (sponsor-unblinded), placebo-controlled study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with moderate to severe rheumatoid arthritis
To investigate the safety and tolerability of 60 mg twice daily doses of GSK2982772 in subjects with moderate to severe Rheumatoid Arthritis.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
To evaluate the efficacy and safety of fluticasone furoate 100mcg administered once daily in the evening in adolescent and adult subjects 12 years of age and older with persistent bronchial asthma o...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared with Ropinirole Immediate Release (IR) Tablets in Subjects with Restless Legs Syndrome (RLS)
To demonstrate the superior tolerability of ropinirole XR compared to ropinirole IR in adult subjects with RLS requiring evening and night-time coverage of RLS symptoms.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
Study B2C111045, A Dose-Finding Study of GW642444 versus Placebo in Patients with COPD
The primary objective of this study is to evaluate the dose response, efficacy and safety of five dosage regimens of LABA GW642444M with lactose and magnesium stearate (3.0mcg, 6.25mcg, 12.5mcg, 25mcg...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110mcg in Adult and Adolescent Subjects 12 years of Age and Older with Perennial Allergic Rhinitis (PAR)
The objective of this study is to compare the efficacy and safety of FFNS 110mcg QD with vehicle placebo nasal spray in subjects with PAR, 12 years of age and older.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
A study to see if it is safe to give a new asthma reliever drug (called vilanterol) to 5 to 11 year old children with asthma
To determine the safety and tolerability following administration of GW642444 25 μg, via a novel dry powder inhaler, once-daily for 7 days in subjects aged 5–11 years.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
A Randomized, Open-Label, 8-Week Cross-Over Study to Compare Umeclidinium/Vilanterol with Tiotropium/Olodaterol Once-Daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD)
To compare the effect of UMEC/VI 62.5/25 mcg with TIO/OLO 5/5mcg once daily on lung function in subjects with moderate COPD over 8 weeks of treatment.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
Clinical phase I/IIA study of subcutaneous administration of Ofatumumab in Rheumatoid Arthritis patients on stable dose Methotrexate
Part A To characterize the safety & tolerability of ofatumumab administered as a single subcut dose in patients with rheumatoid arthritis. Part B To characterize the PK/PD relationship following repea...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
A randomised, double-blind, placebo-controlled, dose ascending, 2-cohort, parallel group study to examine the safety, tolerability and pharmacokinetics of once-daily inhaled doses of GSK573719 formulated with the excipient Magnesium Stearate in COPD subjects for 7 days
To assess the safety and tolerability of repeat inhaled doses of GSK573719 MgSt (inhaled once daily for 7 days) in COPD subjects.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
Assessment of Salmeterol/fluticasone propionate in children with bronchial asthma
To evaluate the safety and efficacy of two inhalations of GW815SF (SLM/FP) HFA MDI 25/50mcg twice daily in paediatric subjects with bronchial asthma.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Précédent
3
4
5
6
7
8
9
10
11
12
Suivant